Philips Healthcare soars in Q3

Philips Healthcare's ($PHG) soaring third-quarter numbers helped generate stellar Q3 numbers for the Dutch conglomerate, Mass Device reports. Imaging systems and sales of home healthcare products jumped in comparable sales by 7%, the company said, and new orders expanded by 6%, year-over-year. The division itself generated $362.9 million in operating income, an increase of more than 34%. Overall sales for healthcare hit $3.19 billion, a 17.6% hike. Release | Story
 

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.